Clinical Trial

hUC-MSC-Exo Therapy for Autoimmune Encephalitis

Name: hUC-MSC-Exo Therapy for Autoimmune Encephalitis — clinical trial record (NCT07131683)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MESAE

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a phase I/IIa study to investigate the safety and preliminary efficacy of intranasal admnistration of human umbilical mesenchymal stem cell-derived exosome (hUC-MSC-Exo) for patients with autoimmune encephalitis.

Trial Details

NCT Number	NCT07131683
Lead Sponsor	Xuanwu Hospital, Beijing Collaborators: ECHO Biotech
Conditions	Autoimmune Encephalitis
Enrollment	38 participants
Start Date	2025-11-01
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-20